GRM1 and ischemia: It was suggested that the activation of presynaptically located mGluR1 inhibits gamma-aminobutyric acid (GABA) release, and thus, the application of mGluR1 antagonists reduces ischemia-induced neurodegeneration by enhancing GABA-mediated neurotransmission.